Chargement en cours...
Sofosbuvir and Simeprevir Therapy for Recurrent Hepatitis C Infection After Liver Transplantation
Antiviral therapy for recurrent hepatitis C in liver transplant recipients has been associated with low efficacy, poor tolerability, and drug-drug interactions. Recent approval of various hepatitis C direct-acting antivirals has resulted in improvement of these parameters. We evaluated the efficacy...
Enregistré dans:
| Publié dans: | Transplant Direct |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Lippincott Williams & Wilkins
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4946469/ https://ncbi.nlm.nih.gov/pubmed/27500223 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000000531 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|